Publication
Development and validation of a pharmacoeconomic tool for decision making in the implementation of pharmaceutical care for hypertensive patients in the Brazilian public health system (SUS)
| dc.contributor.author | Cazarim, Maurílio de Souza | |
| dc.contributor.author | Reis, Rodrigo | |
| dc.contributor.author | Wu, Olívia | |
| dc.contributor.author | Rijo, Rui Pedro Charters Lopes | |
| dc.contributor.author | Vinci, André Luiz Teixeira | |
| dc.contributor.author | Alves, Domingos | |
| dc.contributor.author | Pereira, Leonardo Régis Leira | |
| dc.date.accessioned | 2025-11-04T11:54:46Z | |
| dc.date.available | 2025-11-04T11:54:46Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | Systemic Arterial Hypertension (SAH) is a risk factor for 9.4 million deaths worldwide. In Brazil, the condition attributes an annual cost of approximately USD640,000,000 to the SUS. The epidemiological and economic analysis of Pharmaceutical Care (PC) in the management of hypertensive patients showed an improvement in blood pressure control, a reduction of the risk of SAH complications, and an investment return of over USD1.7 million after ten years. Therefore, this article aims to present a pharmacoeconomic tool capable of assisting decision making in the implementation of PC in the SUS. A systematic review is being conducted for the robustness of the estimation of clinical and epidemiological impact of SAH, its results will be tabulated and applied in the improvement of the tool together with the direct medical and non-medical costs, indirect costs and costs of the SAH. In addition, a Markov model will be designed to estimate the incidence of cardiovascular diseases and SAH’s associated diseases by studies of proteomics that address the Human Network Disease. We hope to validate this auxiliary tool and thus to improve blood pressure control among hypertensive patients, quality of life, to reduce comorbidities and deaths, as well as optimizing the use of health resources. | eng |
| dc.identifier.citation | Maurílio de Souza Cazarim, Rodrigo Reis, Olívia Wu, Rui Pedro Charters Lopes Rijo, André Luiz Teixeira Vinci, Domingos Alves, Leonardo Régis Leira Pereira, Development and validation of a pharmacoeconomic tool for decision making in the implementation of pharmaceutical care for hypertensive patients in the Brazilian public health system (SUS), Procedia Computer Science, Volume 121, 2017, Pages 376-383, ISSN 1877-0509, https://doi.org/10.1016/j.procs.2017.11.051 | |
| dc.identifier.doi | 10.1016/j.procs.2017.11.051 | |
| dc.identifier.issn | 1877-0509 | |
| dc.identifier.uri | http://hdl.handle.net/10400.8/14484 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.publisher | Elsevier BV | |
| dc.relation.hasversion | https://www.sciencedirect.com/science/article/pii/S1877050917322421 | |
| dc.relation.ispartof | Procedia Computer Science | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | Pharmaceutical Services | |
| dc.subject | Hypertension | |
| dc.subject | Economics | |
| dc.subject | Pharmaceutical | |
| dc.subject | Markov Chains | |
| dc.subject | Proteomics | |
| dc.title | Development and validation of a pharmacoeconomic tool for decision making in the implementation of pharmaceutical care for hypertensive patients in the Brazilian public health system (SUS) | eng |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 383 | |
| oaire.citation.startPage | 376 | |
| oaire.citation.title | Procedia Computer Science | |
| oaire.citation.volume | 121 | |
| oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |
| person.familyName | Rijo | |
| person.givenName | Rui | |
| person.identifier.orcid | 0000-0002-9348-0474 | |
| person.identifier.scopus-author-id | 36861366200 | |
| relation.isAuthorOfPublication | e69d7599-392c-4f8f-a96a-bf0a0d15c8b1 | |
| relation.isAuthorOfPublication.latestForDiscovery | e69d7599-392c-4f8f-a96a-bf0a0d15c8b1 |